IDH1 and glioblastoma: Consistent with previous publications [8, 26, 27], patients with mIDH glioblastomas exhibited longer survival relative to those with wild type IDH (Supplemental Figure 1A, p = 0.024 and Supplemental Figure 1B, p = 0.03).